Business Description
Hamilton Thorne Ltd
NAICS : 339112
SIC : 3999
ISIN : CA4078911001
Description
Hamilton Thorne Ltd is engaged in providing precision instruments, consumables, software, and services that reduce cost, increase productivity, improve results, and enable breakthroughs in Assisted Reproductive Technologies (ART), research, and cell biology markets. The company markets its products and services under the Hamilton Thorne, Gynemed, and Embryotech Laboratories brands, through its growing sales force and distributors. The company's customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments. It has a single reporting segment being Engaged in Sales to the ART, Research, and Cell Biology Markets.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.27 | |||||
| Equity-to-Asset | 0.6 | |||||
| Debt-to-Equity | 0.39 | |||||
| Debt-to-EBITDA | 3.57 | |||||
| Interest Coverage | 0.17 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 4.15 | |||||
| Beneish M-Score | -2.43 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 18.8 | |||||
| 3-Year EBITDA Growth Rate | 2.8 | |||||
| 3-Year FCF Growth Rate | -62.8 | |||||
| 3-Year Book Growth Rate | 6.6 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 12.54 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.11 | |||||
| 9-Day RSI | 45.64 | |||||
| 14-Day RSI | 45.54 | |||||
| 3-1 Month Momentum % | 2.29 | |||||
| 6-1 Month Momentum % | 55.54 | |||||
| 12-1 Month Momentum % | 84.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.83 | |||||
| Quick Ratio | 1.05 | |||||
| Cash Ratio | 0.37 | |||||
| Days Inventory | 136.21 | |||||
| Days Sales Outstanding | 44.06 | |||||
| Days Payable | 109.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.1 | |||||
| Shareholder Yield % | -2.84 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 50.92 | |||||
| Operating Margin % | 0.38 | |||||
| Net Margin % | -2.75 | |||||
| FCF Margin % | 2.21 | |||||
| ROE % | -3.36 | |||||
| ROA % | -2.01 | |||||
| ROIC % | 0.48 | |||||
| 3-Year ROIIC % | -3.11 | |||||
| ROC (Joel Greenblatt) % | 0.86 | |||||
| ROCE % | 0.24 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 53 | |||||
| Shiller PE Ratio | 83.11 | |||||
| Price-to-Owner-Earnings | 172.31 | |||||
| PS Ratio | 3.31 | |||||
| PB Ratio | 3.9 | |||||
| Price-to-Tangible-Book | 39.75 | |||||
| Price-to-Free-Cash-Flow | 140 | |||||
| Price-to-Operating-Cash-Flow | 41.48 | |||||
| EV-to-EBIT | 1311.35 | |||||
| EV-to-EBITDA | 38.76 | |||||
| EV-to-Revenue | 3.59 | |||||
| EV-to-Forward-Revenue | 3.02 | |||||
| EV-to-FCF | 161 | |||||
| Price-to-GF-Value | 1.03 | |||||
| Price-to-Projected-FCF | 3 | |||||
| Price-to-Median-PS-Value | 1.05 | |||||
| Earnings Yield (Greenblatt) % | 0.08 | |||||
| FCF Yield % | 0.67 | |||||
| Forward Rate of Return (Yacktman) % | -0.68 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:HTLZF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hamilton Thorne Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 76.301 | ||
| EPS (TTM) ($) | -0.017 | ||
| Beta | 0.09 | ||
| 3-Year Sharpe Ratio | -0.02 | ||
| 3-Year Sortino Ratio | -0.05 | ||
| Volatility % | 45.18 | ||
| 14-Day RSI | 45.54 | ||
| 14-Day ATR ($) | 0.005498 | ||
| 20-Day SMA ($) | 1.59766 | ||
| 12-1 Month Momentum % | 84.23 | ||
| 52-Week Range ($) | 0.9039 - 1.625 | ||
| Shares Outstanding (Mil) | 154.17 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hamilton Thorne Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hamilton Thorne Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hamilton Thorne Ltd Frequently Asked Questions
What is Hamilton Thorne Ltd(HTLZF)'s stock price today?
The current price of HTLZF is $1.59. The 52 week high of HTLZF is $1.63 and 52 week low is $0.90.
When is next earnings date of Hamilton Thorne Ltd(HTLZF)?
The next earnings date of Hamilton Thorne Ltd(HTLZF) is 2025-03-27 Est..
Does Hamilton Thorne Ltd(HTLZF) pay dividends? If so, how much?
Hamilton Thorne Ltd(HTLZF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers